ATE338770T1 - Mit bh4 fusionierte polypeptide - Google Patents

Mit bh4 fusionierte polypeptide

Info

Publication number
ATE338770T1
ATE338770T1 AT00985913T AT00985913T ATE338770T1 AT E338770 T1 ATE338770 T1 AT E338770T1 AT 00985913 T AT00985913 T AT 00985913T AT 00985913 T AT00985913 T AT 00985913T AT E338770 T1 ATE338770 T1 AT E338770T1
Authority
AT
Austria
Prior art keywords
amino acid
acid sequence
apoptosis
ischemic disease
sequence
Prior art date
Application number
AT00985913T
Other languages
English (en)
Inventor
Shigeomi Shimizu
Yoshihide Tsujimoto
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE338770T1 publication Critical patent/ATE338770T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT00985913T 1999-12-27 2000-12-26 Mit bh4 fusionierte polypeptide ATE338770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP37144999 1999-12-27

Publications (1)

Publication Number Publication Date
ATE338770T1 true ATE338770T1 (de) 2006-09-15

Family

ID=18498735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985913T ATE338770T1 (de) 1999-12-27 2000-12-26 Mit bh4 fusionierte polypeptide

Country Status (6)

Country Link
US (1) US20030152946A1 (de)
EP (1) EP1243595B1 (de)
JP (1) JP3906078B2 (de)
AT (1) ATE338770T1 (de)
DE (1) DE60030587T2 (de)
WO (1) WO2001048014A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077826A1 (en) * 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
EP3211084B1 (de) * 2003-05-16 2019-03-27 Acorda Therapeutics, Inc. Proteoglycan-abbauende mutanten zur behandlung des zns
FR2860237B1 (fr) 2003-09-30 2006-03-10 Centre Nat Rech Scient Polypeptide d'interaction comprenant un motif heptapeptidique et un domaine de penetration cellulaire
US20070154962A1 (en) * 2005-12-23 2007-07-05 Giulio Taglialatela Bcl-2 promoted cell death
CN102272142A (zh) * 2008-12-23 2011-12-07 帷幄生物技术公司 非遗传修饰性重编程细胞的组合物和方法
WO2016018454A2 (en) * 2014-06-18 2016-02-04 Cisthera, Inc. Compositions and methods employing bcl2 and bcl2 family members
WO2017189826A1 (en) * 2016-04-29 2017-11-02 Portage Pharmaceuticals Ltd. Use of cell-permeable peptides and non-peptide carriers conjugated with nemo binding domain cargo sequence for the treatment of dry eye disease and uveitis
JP7204734B2 (ja) 2017-08-01 2023-01-16 オーアンドエム ハリヤード インターナショナル アンリミテッド カンパニー 滅菌野を提供するためのポケットアンドドレープシステム

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646008A (en) * 1993-06-22 1997-07-08 The Regent Of The University Of Michigan Vertebrate apoptosis gene: compositions and methods

Also Published As

Publication number Publication date
EP1243595A1 (de) 2002-09-25
EP1243595B1 (de) 2006-09-06
JP3906078B2 (ja) 2007-04-18
DE60030587T2 (de) 2007-05-31
EP1243595A4 (de) 2004-08-04
WO2001048014A1 (fr) 2001-07-05
US20030152946A1 (en) 2003-08-14
DE60030587D1 (de) 2006-10-19

Similar Documents

Publication Publication Date Title
DE69912434D1 (de) Pharmazeutische zusammensetzung zur behandlung einer funktionalen dyspepsie und/oder des reizdarmsyndroms und die verwendung neuer substanzen in dieser zusammensetzung
IL151371A0 (en) Modified porcine factor viii and pharmaceutical compositions containing the same
BR0109494A (pt) Produção de fatores recombinantes de coagulação do sangue em linhas celulares humanas
RU99107759A (ru) Применение антагонистов лептина для лечения резистентности к инсулину при диабете ii типа
DK1539964T3 (da) Cellectin-komplementaktiverende proteinkimærer
ATE165976T1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
EP0922055A4 (de) Conotoxin peptid pviia
ATE338770T1 (de) Mit bh4 fusionierte polypeptide
ATE409493T1 (de) Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung
WO2003035679A3 (en) Molecules
ATE403726T1 (de) Cytokin-proteinfamilie
NO920777L (no) Anti-thrombinpolypeptider
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
BR0111852A (pt) Nova interferona para o tratamento de esclerose múltipla
JP2004513615A5 (de)
DE59409413D1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
KR960000248A (ko) 골대사 질환 치료제
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
JP2004505616A5 (de)
WO2001098355A3 (en) Cgi-69 compositions and methods of use
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
CA2180683A1 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties